The US Preventive Services Task Force (USPSTF) recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21-29 years and screening every 3 years with cervical cytology alone, every 5 years with high-risk human papillomavirus (hrHPV) testing alone, or every 5 years with hrHPV testing in combination with cytology in women aged 30-65 years, according to its new recommendation statement on screening for cervical cancer. The other USPSTF recommendations include:

• The USPSTF recommends screening for cervical cancer in women < age 21 years.
• The USPSTF recommends against screening for cervical cancer in women aged >65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer.
• The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion or cervical cancer.